Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · IEX Real-Time Price · USD
20.66
-0.87 (-4.04%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Syndax Pharmaceuticals Employees
Syndax Pharmaceuticals had 184 employees as of December 31, 2023. The number of employees increased by 77 or 71.96% compared to the previous year.
Employees
184
Change (1Y)
77
Growth (1Y)
71.96%
Revenue / Employee
n/a
Profits / Employee
-$1,307,793
Market Cap
1.76B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 184 | 77 | 71.96% |
Dec 31, 2022 | 107 | 48 | 81.36% |
Dec 31, 2021 | 59 | 16 | 37.21% |
Dec 31, 2020 | 43 | 8 | 22.86% |
Dec 31, 2019 | 35 | -3 | -7.89% |
Dec 31, 2018 | 38 | -6 | -13.64% |
Dec 31, 2017 | 44 | 12 | 37.50% |
Dec 31, 2016 | 32 | 16 | 100.00% |
Dec 31, 2015 | 16 | 3 | 23.08% |
Nov 21, 2014 | 13 | 0 | - |
Dec 31, 2013 | 13 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
AMN Healthcare Services | 18,223 |
NeoGenomics | 2,100 |
Novavax | 1,543 |
NovoCure | 1,453 |
LeMaitre Vascular | 630 |
Immunocore Holdings | 497 |
Rocket Pharmaceuticals | 268 |
Catalyst Pharmaceuticals | 167 |
SNDX News
- 18 days ago - Syndax Presents Updated Positive Data from BEAT AML and AUGMENT-102 Phase 1/2 Combination Trials of Revumenib in Patients with Acute Leukemias at EHA 2024 Congress - PRNewsWire
- 26 days ago - Syndax Announces Plans to Advance into Phase 1b Portion of Trial Evaluating Revumenib in Relapsed or Refractory Metastatic MSS CRC - PRNewsWire
- 27 days ago - Syndax Announces Participation at the Goldman Sachs 45th Annual Global Healthcare Conference - PRNewsWire
- 4 weeks ago - Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PRNewsWire
- 6 weeks ago - Syndax Pharmaceuticals Appoints Aleksandra Rizo, M.D., Ph.D. to the Board of Directors - PRNewsWire
- 7 weeks ago - Syndax Announces Participation at the Bank of America Securities 2024 Health Care Conference - PRNewsWire
- 7 weeks ago - Syndax Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Clinical and Business Update - PRNewsWire
- 2 months ago - Syndax to Announce First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 8, 2024 - PRNewsWire